Association of self-DNA mediated TLR9-related gene, DNA methyltransferase, and cytokeratin protein expression alterations in HT29-Cells to DNA fragment length and methylation status

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Furi, István ^a   Sipos, Ferenc ^a   Spisák, Sándor ^b   Kiszner, Gergo ^a   Wichmann, Barnabás ^a   Schöller, Andrea ^a   Tulassay, Zsolt ^b   Muzes, Györgyi ^a   Molnár, Béla ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; DNA; DNA (CYTOSINE 5) METHYLTRANSFERASE; IL8 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK3 PROTEIN, HUMAN; KERATIN; MYD88 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN HT29; COLON ADENOCARCINOMA; DNA FRAGMENTATION; DNA METHYLATION; DNA PURIFICATION; DNA SEQUENCE; DNA STRUCTURE; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; IMMUNOREACTIVITY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-8; KERATINS; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; TNF RECEPTOR-ASSOCIATED FACTOR 6; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TOLL-LIKE RECEPTOR 9;

EID: 84896381927     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/293296     Document Type: Article

References (33)

1. Gosu V., Basith S., Kwon O. P., Choi S., Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling. Molecules 2012 17 13503 13529
2. Akira S., Takeda K., Toll-like receptor signalling. Nature Reviews Immunology 2004 4 7 499 511 2-s2.0-3142724031 (Pubitemid 38931765)
3. Nierkens S., den Brok M. H., Garcia Z., Togher S., Wagenaars J., Wassink M., Boon L., Ruers T. J., Figdor C. G., Schoenberger S. P., Adema G. J., Janssen E. M., Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells. Cancer Research 2011 71 20 6428 6437 2-s2.0-80054015074 10.1158/0008-5472.CAN-11-2154
4. Liang X., Moseman E. A., Farrar M. A., Bachanova V., Weisdorf D. J., Blazar B. R., Chen W., Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells. Blood 2010 115 24 5041 5052 2-s2.0-77954662424 10.1182/blood-2009-03-213363
5. Sipos F., Muzes G., Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer? World Journal of Gastroenterology 2011 17 13 1666 1673 2-s2.0-79955961130 10.3748/wjg.v17.i13.1666
6. Fischer M., Ehlers M., Toll-like receptors in autoimmunity. Annals of the New York Academy of Sciences 2008 1143 21 34 2-s2.0-56549093441 10.1196/annals.1443.012
7. Ewaschuk J. B., Backer J. L., Churchill T. A., Obermeier F., Krause D. O., Madsen K. L., Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infection and Immunity 2007 75 5 2572 2579 2-s2.0-34248397191 10.1128/IAI.01662-06 (Pubitemid 46744349)
8. Lee J., Mo J. H., Katakura K., Alkalay I., Rucker A. N., Liu Y.-T., Lee H.-K., Shen C., Cojocaru G., Shenouda S., Kagnoff M., Eckmann L., Ben-Neriah Y., Raz E., Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nature Cell Biology 2006 8 12 1327 1336 2-s2.0-33751551466 10.1038/ncb1500 (Pubitemid 44835107)
9. Akira S., Hemmi H., Recognition of pathogen-associated molecular patterns by TLR family. Immunology Letters 2003 85 2 85 95 2-s2.0-0037460116 10.1016/S0165-2478(02)00228-6 (Pubitemid 36071561)
10. Kanzler H., Barrat F. J., Hessel E. M., Coffman R. L., Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nature Medicine 2007 13 5 552 559 2-s2.0-34249677845 10.1038/nm1589 (Pubitemid 46830615)
11. Kauppila J. H., Karttunen T. J., Saarnio J., Nyberg P., Salo T., Graves D. E., Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion. APMIS 2013 121 6 511 522 10.1111/apm.12016
12. Häcker H., Mischak H., Miethke T., Liptay S., Schmid R., Sparwasser T., Heeg K., Lipford G. B., Wagner H., CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. The EMBO Journal 1998 17 21 6230 6240 2-s2.0-0032476602 10.1093/emboj/17.21.6230 (Pubitemid 28497796)
13. Klaschik S., Tross D., Klinman D. M., Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo. Journal of Leukocyte Biology 2009 85 5 788 795 2-s2.0-65549140232 10.1189/jlb.1008671
14. Ito S. I., Ishii K. J., Shirota H., Klinman D. M., CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection. Infection and Immunity 2004 72 6 3543 3548 2-s2.0-2542620714 10.1128/IAI.72.6.3543-3548.2004 (Pubitemid 38697782)
15. Verthelyi D., Gursel M., Kenney R. T., Lifson J. D., Liu S., Mican J., Klinman D. M., CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection. The Journal of Immunology 2003 170 9 4717 4723 2-s2.0-0037407856 (Pubitemid 36519979)
16. Klaschik S., Tross D., Shirota H., Klinman D. M., Short- and long-term changes in gene expression mediated by the activation of TLR9. Molecular Immunology 2010 47 6 1317 1324 2-s2.0-76949088399 10.1016/j.molimm.2009.11.014
17. Ilvesaro J. M., Merrell M. A., Li L., Wakchoure S., Graves D., Brooks S., Rahko E., Jukkola-Vuorinen A., Vuopala K. S., Harris K. W., Selander K. S., Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion. Molecular Cancer Research 2008 6 10 1534 1543 2-s2.0-54249157845 10.1158/1541-7786.MCR-07-2005
18. Huidobro C., Urdinguio R. G., Rodríguez R. M., Mangas C., Calvanese V., Martínez-Camblor P., Ferrero C., Parra-Blanco A., Rodrigo L., Obaya Á. J., Suárez-Fernández L., Astudillo A., Hernando H., Ballestar E., Fernández A. F., Fraga M. F., A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer. European Journal of Cancer 2012 48 2270 2281 2-s2.0-84855610005 10.1016/j.ejca.2011.12.019
19. Renbaum P., Abrahamove D., Fainsod A., Wilson G. G., Rottem S., Razin A., Cloning, characterization, and expression in Escherichia coli of the gene coding for the CpG DNA methylase from Spiroplasma sp. strain MQ1 (M·SssI). Nucleic Acids Research 1990 18 5 1145 1152 2-s2.0-0025220507
20. Ilvesaro J. M., Merrell M. A., Swain T. M., Davidson J., Zayzafoon M., Harris K. W., Selander K. S., Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 2007 67 7 774 781 2-s2.0-34248175039 10.1002/pros.20562 (Pubitemid 46709446)
21. Schaefer T. M., Desouza K., Fahey J. V., Beagley K. W., Wira C. R., Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004 112 3 428 436 2-s2.0-3042789092 10.1111/j.1365-2567.2004.01898.x (Pubitemid 38859521)
22. Schmaußer B., Andrulis M., Endrich S., Müller-Hermelink H. K., Eck M., Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. International Journal of Medical Microbiology 2005 295 3 179 185 2-s2.0-20144373185 10.1016/j.ijmm.2005. 02.009 (Pubitemid 40776102)
23. Droemann D., Albrecht D., Gerdes J., Ulmer A. J., Branscheid D., Vollmer E., Dalhoff K., Zabel P., Goldmann T., Human lung cancer cells express functionally active Toll-like receptor 9. Respiratory Research 2005 6, article 1 2-s2.0-25444470242 10.1186/1465-9921-6-1 (Pubitemid 41357885)
24. Merrell M. A., Ilvesaro J. M., Lehtonen N., Sorsa T., Gehrs B., Rosenthal E., Chen D., Shackley B., Harris K. W., Selander K. S., Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Molecular Cancer Research 2006 4 7 437 447 2-s2.0-33746882098 10.1158/1541-7786.MCR-06-0007 (Pubitemid 44197039)
25. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S., A Toll-like receptor recognizes bacterial DNA. Nature 2000 408 6813 740 745 2-s2.0-0034619794 10.1038/35047123 (Pubitemid 32015992)
26. Eads C. A., Danenberg K. D., Kawakami K., Saltz L. B., Danenberg P. V., Laird P. W., CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Research 1999 59 10 2302 2306 2-s2.0-0033563083 (Pubitemid 29242272)
27. Oh B. K., Kim H., Park H. J., Shim Y. H., Choi J., Park C., Park Y. N., DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. International Journal of Molecular Medicine 2007 20 1 65 73 2-s2.0-34548074239
28. Ding W.-J., Fang J.-Y., Chen X.-Y., Peng Y.-S., The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Digestive Diseases and Sciences 2008 53 8 2083 2089 2-s2.0-46449115224 10.1007/s10620-007-0145-2
29. Fang J. Y., Lu R., Mikovits J. A., Cheng Z. H., Zhu H. Y., Chen Y. X., Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1. Cancer Letters 2006 233 1 124 130 2-s2.0-32244444440 10.1016/j.canlet.2005.03.005 (Pubitemid 43214570)
30. Geiman T. M., Sankpal U. T., Robertson A. K., Chen Y., Mazumdar M., Heale J. T., Schmiesing J. A., Kim W., Yokomori K., Zhao Y., Robertson K. D., Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. Nucleic Acids Research 2004 32 9 2716 2729 2-s2.0-2542583103 10.1093/nar/gkh589 (Pubitemid 38885943)
31. Fang J. Y., Cheng Z. H., Chen Y. X., Lu R., Yang L., Zhu H.-Y., Lu L.-G., Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. World Journal of Gastroenterology 2004 10 23 3394 3398 2-s2.0-9244221588 (Pubitemid 39549535)
32. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C., Volinia S., Guler G., Morrison C. D., Chan K. K., Marcucci G., Calin G. A., Huebner K., Croce C. M., MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proceedings of the National Academy of Sciences of the United States of America 2007 104 40 15805 15810 2-s2.0-35649020283 10.1073/pnas.0707628104 (Pubitemid 350035380)
33. Singh V., Sharma P., Capalash N., DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer. Current Cancer Drug Targets 2013 13 4 379 399